Scorpius Holdings Inc 's ability to collect accounts receivable sequentially worsen to 12.3, indicating more challenging environment then in the second quarter 2025, but still, it is a far cry from any concerns. Scorpius Holdings Inc 's Accounts Receivable average collection period in the Sep 30 2025 quarter, has increased to 30 days, from 22 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 482 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 3070 to 3224.

What is Receivable Turnover Ratio?
What is Scorpius Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SCPX Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-11.42 %	-98.1 %	-60.79 %	-61.76 %	-35.31 %
Y / Y Revenue Change	-75.08 %	-70.06 %	-93.96 %	-78.41 %	27.55 %
Receivable Turnover Ratio (TTM)	12.3	16.57	6.27	11.34	16.51
SCPX's Total Ranking	# 3224	# 3070	# 3236	# 1038	# 0
Accounts Receivable average collection period days	30	22	58	32	22
Seq. Receivable Change	617.88 %	-88.05 %	46.22 %	-29.35 %	-84.61 %
Seq. Revenue Change	1.01 %	7.19 %	-79.72 %	13.49 %	21.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 169
Healthcare Sector	# 483
Overall Market	# 3224

Receivable Turnover Ratio Statistics
High	Average	Low
0.18	0.08	0.01
(Dec 31 2018)		(Jun 30 2022)

SCPX Company Profile • Back to SCPX Efficiency Comparisons • Compare SCPX Receivables Turnover Ratio to its Competitors

Financial Statements
Scorpius Holdings Inc 's Accounts Receivable	$ 0 Millions	Visit SCPX's Balance sheet
Scorpius Holdings Inc 's Sales TTM	$ 2 Millions	Visit SCPX's Income Statement
Sources of SCPX's Revenues		Visit SCPX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SCPX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SCPX's Growth Rates	SCPX's Roa	SCPX's Inventory Turnover Ratio	SCPX's Dividend Comparisons
SCPX's Profitability Ratios	SCPX's Roi	SCPX's Asset Turnover Ratio	SCPX's Dividend Growth
SCPX's Valuation Ratios	SCPX's Roe	SCPX's Financial Strength Ratios	SCPX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Cv Sciences Inc	24.73	$ 11.758 Millions	$ 0.476 Millions
Aquestive Therapeutics Inc	23.64	$ 43.397 Millions	$ 1.836 Millions
Aim Immunotech Inc	23.58	$ 0.112 Millions	$ 0.005 Millions
Safe Pro Group Inc	23.20	$ 1.267 Millions	$ 0.055 Millions
Fonar Corporation	22.87	$ 105.434 Millions	$ 4.609 Millions
Electrocore Inc	22.58	$ 28.883 Millions	$ 1.279 Millions
Immunocore Holdings Plc	22.33	$ 379.590 Millions	$ 16.997 Millions
Innovage Holding Corp	21.40	$ 884.662 Millions	$ 41.330 Millions
Orthofix Medical Inc	21.02	$ 818.516 Millions	$ 38.934 Millions
Arvinas Inc	20.82	$ 312.300 Millions	$ 15.000 Millions
Spero Therapeutics Inc	20.78	$ 40.549 Millions	$ 1.951 Millions
Neuroone Medical Technologies Corp	20.67	$ 9.098 Millions	$ 0.440 Millions
Plus Therapeutics Inc	20.60	$ 5.258 Millions	$ 0.255 Millions
Bioxcel Therapeutics Inc	20.32	$ 0.752 Millions	$ 0.037 Millions
Sonida Senior Living Inc	19.17	$ 375.417 Millions	$ 19.582 Millions
Nutriband Inc	19.13	$ 2.278 Millions	$ 0.119 Millions
Bespoke Extracts Inc	19.07	$ 1.423 Millions	$ 0.075 Millions
Generation Bio Co	18.72	$ 15.270 Millions	$ 0.816 Millions
Neuraxis Inc	18.54	$ 3.362 Millions	$ 0.181 Millions
Siga Technologies Inc	18.46	$ 172.250 Millions	$ 9.332 Millions
Petvivo Holdings Inc	17.90	$ 1.088 Millions	$ 0.061 Millions
Nurix Therapeutics Inc	17.62	$ 83.687 Millions	$ 4.750 Millions
Precipio inc	17.47	$ 22.800 Millions	$ 1.305 Millions
Marpai Inc	17.32	$ 20.702 Millions	$ 1.195 Millions
Lucid Diagnostics Inc	17.10	$ 4.399 Millions	$ 0.257 Millions
Valion Bio Inc	16.91	$ 0.482 Millions	$ 0.029 Millions
Meiragtx Holdings Plc	16.70	$ 27.417 Millions	$ 1.642 Millions
Talkspace Inc	16.12	$ 214.505 Millions	$ 13.310 Millions
Voyager Therapeutics Inc	15.68	$ 31.316 Millions	$ 1.997 Millions
Amneal Pharmaceuticals Inc	15.06	$ 2,933.636 Millions	$ 194.776 Millions

Date modified: 2026-09-08T22:08:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.